...
机译:预先存在的侵袭性真菌感染对血液学恶性肿瘤患者的同种异体HSCT不是同种异体HSCT的禁忌症:CIBMTR研究
Oregon Hlth &
Sci Univ Adult Blood &
Marrow Stem Cell Transplant Program Knight Canc Inst 3181;
Med Coll Wisconsin Dept Med CIBMTR Milwaukee WI 53226 USA;
Med Coll Wisconsin Dept Med CIBMTR Milwaukee WI 53226 USA;
Oregon Hlth &
Sci Univ Adult Blood &
Marrow Stem Cell Transplant Program Knight Canc Inst 3181;
Hosp Santa Creu &
Sant Pau Div Clin Hematol Barcelona Spain;
Univ Florida Dept Med Div Hematol &
Oncol Gainesville FL USA;
King Faisal Specialist Hosp Ctr &
Res Dept Oncol Riyadh Saudi Arabia;
NHLBI Hematol Branch Bethesda MD 20892 USA;
Univ Calif San Francisco Dept Pediat Med Ctr San Francisco CA USA;
Christian Med Coll &
Hosp Dept Hematol Vellore Tamil Nadu India;
Dana Farber Canc Inst Dept Pediat Oncol Boston MA 02115 USA;
All Childrens Hosp Dept Hematol Oncol St Petersburg FL USA;
Univ Hosp Case Med Ctr Seidman Canc Ctr Cleveland OH USA;
Catholic Univ Korea Seoul St Marys Hosp BMT Ctr Seoul South Korea;
Univ Rochester Med Ctr Dept Med Rochester NY 14642 USA;
UMass Mem Med Ctr Dept Med Div Hematol &
Oncol Worcester MA USA;
Univ Cent Florida Coll Med Dept Internal Med Orlando FL 32816 USA;
Vanderbilt Univ Med Ctr Dept Med Div Hematol Oncol Nashville TN USA;
Univ Cincinnati Inst Canc Cincinnati OH USA;
Oregon Hlth &
Sci Univ Infect Dis Clin Portland OR 97201 USA;
UC San Diego Hlth Infect Dis Program La Jolla CA USA;
Univ Minnesota Med Ctr Div Hematol Oncol &
Transplantat Dept Med Minneapolis MN 55455 USA;
Fred Hutchinson Canc Res Ctr Vaccine &
Infect Dis Div 1124 Columbia St Seattle WA 98104 USA;
NCI Expt Transplantat &
Immunol Branch NIH Bethesda MD 20892 USA;
Univ Med Ctr Utrecht Pediat Blood &
Marrow Transplantat Program Utrecht Netherlands;
Nationwide Childrens Hosp Div Hematol Oncol Columbus OH USA;
Univ North Carolina Chapel Hill Div Hematol Oncol Chapel Hill NC USA;
机译:对于有血液系统恶性肿瘤的成年患者,先前的侵袭性真菌感染并不是随后的同种异体骨髓移植的禁忌症。
机译:异基因造血干细胞移植后CD4 + T细胞的免疫重建及其与恶性血液病患者侵袭性真菌感染的关系
机译:β-葡聚糖抗原血症检测对血液系统恶性肿瘤患者侵袭性真菌感染的诊断:第三次欧洲白血病感染会议(ECIL-3)的队列研究的系统评价和荟萃分析
机译:设计血液学恶性肿瘤患者的会话剂:可用性和有用性研究
机译:在没有积极免疫和批准治疗的情况下,血液恶性肿瘤和造血干细胞移植(HSCT)患者的副流感病毒感染负担:感染控制的作用。
机译:已有的侵袭性真菌感染并非血液系统恶性肿瘤患者异基因HSCT的禁忌症:一项CIBMTR®研究
机译:预先存在的侵袭性真菌感染对血液学恶性肿瘤患者的同种异体HSCT是同种异体HSCT的禁忌症:CIBMTR研究
机译:体外扩增(EVE)巨核细胞(mK)用于乳腺癌血液恶性肿瘤患者的支持治疗:I / II期临床研究